Buy Alert: This Pot Stock Just Gained 26%

Namaste (TSXV:N) stock might be a top contrarian pick for investors with a large risk appetite.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Marijuana stocks are extremely volatile. Any news surrounding the company or the sector generally results in a significant movement of cannabis stock prices. Yesterday, shares of Namaste Technologies (TSXV:N) soared over 26% to close trading at $0.31. However, there was no company-specific or even sector-specific news surrounding Namaste that drove the stock higher.

Similar to most cannabis stocks, Namaste has also burnt significant investor wealth in the last 18 months. Namaste stock has lost close to 90% in market value since September 2018 and is down 22% year to date. Let’s take a look to see if the company can stage a turnaround by the end of 2020.

Namaste is an e-commerce platform

Namaste Technologies is a cannabis e-commerce company and sells vapes as well as smoking accessories in five countries through nine e-commerce sites. This packaged goods company is focused on the distribution and manufacturing of medical cannabis, cannabis-derived products, and accessories to customers in Canada, Europe, and Australia.

Namaste aims to build a scalable infrastructure that will create a foundation of growth and expansion opportunities in the upcoming decade. These strategies are targeted at improving gross profit, reducing non-strategic spending, and improving efficiencies.

This has allowed Namaste’s management to introduce new product lines to consumers, which have helped the company increase sales in the last few quarters. In the second quarter of 2020, Namaste reported sales of $6.92 million, indicating year-over-year growth of 73% compared with sales of $4 million in the prior-year quarter.

In the first six months of 2020, its sales grew to $12.23 million, up from $8.6 million in the prior-year period. Namaste attributed the revenue growth to the sales of cannabis products, which rose by $2.2 million in Q2.

A significant drop in gross profit

However, Namaste’s gross margin in Q2 stood at a paltry 9% compared with 18% in Q2 of 2019. This meant Namaste reported an adjusted EBITDA loss of $4.7 million, well above its EBITDA loss of $3.9 million in the prior-year quarter. This massive decline in gross margin was attributed to a change in product mix.

While Namaste’s sales were up 73%, operating costs rose less than 12%, indicating high operating leverage. This should allow the company to improve the bottom line if it manages to reduce the cost of sales in the upcoming quarters.

Namaste said, “The company has implemented new strategies targeted at reducing corporate overhead and building the infrastructure to support the corporate vision. The execution of these transformational strategies is partially reflected in the results. Full annualized savings are anticipated to be realized in 2021.”

In the fourth quarter of 2019, Namaste’s quarterly loss stood at $29.7 million, and the company has now managed to reduce net losses for two consecutive quarters on a sequential basis.

What’s next for Namaste investors?

In Q2, Namaste’s Canadian sales rose 338% year over year and accounted for 48% of total sales, up from just 19% in the May 2019 quarter. Despite a revenue decline in other international markets, the company’s sales rose in Australia, Denmark, Germany, the U.K., and the U.S.

Further, the company’s revenue growth momentum might continue to gain pace in the upcoming quarters especially if its subsidiary CannMart Labs receives licences to produce cannabis extracts in 2021.

However, Namaste needs to improve profitability given its cash balance was $20.4 million at the end of May and it used $6.6 million in Q2.

Should you invest $1,000 in Allied Properties Real Estate Investment Trust right now?

Before you buy stock in Allied Properties Real Estate Investment Trust, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Allied Properties Real Estate Investment Trust wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Namaste Technologies. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »